These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3231380)

  • 1. AIDS antibodies may enhance viral infection.
    Glaser V
    N Y State J Med; 1988 Oct; 88(10):564. PubMed ID: 3231380
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV mutation rate.
    Nowak M
    Nature; 1990 Oct; 347(6293):522. PubMed ID: 2215679
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infection by HIV and AIDS].
    Gluckman JC
    Ann Biol Clin (Paris); 1988; 46(1):35-6. PubMed ID: 3164598
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of infection with human immunodeficiency virus.
    Ho DD; Pomerantz RJ; Kaplan JC
    N Engl J Med; 1987 Jul; 317(5):278-86. PubMed ID: 3299092
    [No Abstract]   [Full Text] [Related]  

  • 5. [From HIV infection to AIDS].
    Gluckman JC; Klatzmann D
    Nouv Rev Fr Hematol (1978); 1987; 29(1):9-12. PubMed ID: 3647357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-antibodies in tears of patients with AIDS.
    Liotet S; Hartmann C; Batellier L; Chaumeil C; Frottier J
    Fortschr Ophthalmol; 1987; 84(4):340-1. PubMed ID: 3478293
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistence of anti-HIV p24 antibodies in African AIDS patient.
    van den Akker R; Bouman-van Engelen CA; de Jong JC; Dolmans WM; van Loon AM; Mulder DW; Shao JF
    AIDS; 1988 Feb; 2(1):62-3. PubMed ID: 3129000
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of HTLV III/LAV envelope protein.
    Bicker U
    Nature; 1986 Nov 27-Dec 3; 324(6095):307. PubMed ID: 3466037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical manifestations of acquired immunologic deficiency syndrome (AIDS)].
    Goebel FD
    Acta Med Austriaca; 1987; 14(1):1-4. PubMed ID: 3475926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS vaccine predictions.
    Barin F
    Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for antibodies to HIV (AIDS agent): application, interpretation and follow-up.
    Guarda NP; Peterson JZ
    Fla Nurse; 1986; 34(10):20-1. PubMed ID: 3466813
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal serologic evaluation of an infant with acquired immunodeficiency syndrome.
    Krilov LR; Kamani N; Hendry RM; Wittek AE; Quinnan GV
    Pediatr Infect Dis J; 1987 Nov; 6(11):1066-7. PubMed ID: 3480501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphopathic HTLV-III-LAV infection and acquired immunodeficiency syndrome].
    Pokrovskiĭ VV
    Ter Arkh; 1986; 58(10):151-4. PubMed ID: 3541273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy.
    Epstein LG; Goudsmit J; Paul DA; Morrison SH; Connor EM; Oleske JM; Holland B
    Ann Neurol; 1987 Apr; 21(4):397-401. PubMed ID: 3472486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of circulating immune complexes in HIV-related diseases.
    Carini C; D'Amelio R; Mezzaroma I; Aiuti F
    Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
    Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
    J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of HIV vaccine.
    Robson B; Fishleigh RV; Morrison CA
    Nature; 1987 Jan 29-Feb 4; 325(6103):395. PubMed ID: 3468356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polyclonal B cell activation in infection caused by human immunodeficiency virus (HIV)].
    Exquis B; Perrin L; Link L; Scrignari V; Hirschel B; Zubler R; Miescher PA
    Schweiz Med Wochenschr; 1987 Nov; 117(47):1863-5. PubMed ID: 3501163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.